631911-94-9

Basic information

• Product Name: Benzoic acid, 2-amino-3-methyl-5-nitro-, methyl ester (9CI)
• Synonyms: Benzoic acid, 2-amino-3-methyl-5-nitro-, methyl ester (9CI)
• CAS NO: 631911-94-9
• Molecular Formula: C₉H₁₀N₂O₄
• Molecular Weight: 210.1867
• Product Categories: AMINOACID
• Mol File: 631911-94-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzoic acid, 2-amino-3-methyl-5-nitro-, methyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-amino-3-methyl-5-nitro-, methyl ester (9CI)(631911-94-9)
• EPA Substance Registry System: Benzoic acid, 2-amino-3-methyl-5-nitro-, methyl ester (9CI)(631911-94-9)

Safety Data

• Hazardous Substances Data: 631911-94-9(Hazardous Substances Data)

Upstream product

• 66176-17-8 6-methylisatoic anhydride 
• 4389-45-1 3-methylantranilic acid 
• 500028-91-1 8-methyl-6-nitro-1H-benzo[d][1,3]oxazine-2,4-dione 

Downstream Products

• 631911-95-0 2-bromo-3-methyl-5-nitrobenzoic acid 
• 631911-96-1 (2-bromo-3-methyl-5-nitro-phenyl)-carbamic acid tert-butyl ester 
• 179897-93-9 methyl 2-bromo-3-methyl-5-nitrobenzoate 

Relevant articles and documents

Conjugated complement cascade inhibitors

The present invention is directed to conjugated complement cascade inhibitors, and a method of treating a patient using a conjugated complement cascade inhibitor.

NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS

Disclosed is a method for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula (I) or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R1, R2, R3, R4 and R7 are defined in the specification, Z is SO or SO2, and Ar is an aromatic or heteroaromatic group as defined herein.